Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery

Status Completed

Clinical Trial Summary

This study evaluates the clinical efficacy and cost effectiveness of Prevena Incision Management System versus Dermabond in preventing groin wound infections in patients who undergo vascular surgery requiring a groin wound. Half of the patients will receive Dermabond and the other half will receive the Prevena Incision Management System for their groin wounds.

Clinical Trial Description

Dermabond and the Prevena Incision Management System are both FDA approved wound care products. Prevena is a negative pressure system which holds the wound together and removes exudate and debris from the site to prevent infection. Dermabond is a surgical glue which holds the wound together to prevents infection. Prevena is more expensive to apply. However, the hypothesis is that the Prevena System will decrease infection rates and therefore, decrease the ultimate cost of the health care needed after surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02836990
Study type	Interventional
Source	State University of New York at Buffalo
Contact
Status	Completed
Phase	N/A
Start date	July 2016
Completion date	September 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02905955` - Vacuumtherapy After Venous Hybrid Procedures	Phase 4
Not yet recruiting	`NCT02868372` - Swabbing of Subcutaneous Tissues of Cesarean Section Wounds With Povidone Iodine	N/A
Enrolling by invitation	`NCT02559453` - Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds	N/A
Completed	`NCT02744144` - Wound Bacterial Microbiota and Their Antibiotic Resistance	N/A
Active, not recruiting	`NCT01939145` - Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation	Phase 4
Completed	`NCT00998907` - PDS*Plus and Wound Infections After Laparotomy	N/A
Completed	`NCT01141335` - Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair	Phase 4
Terminated	`NCT00654641` - Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy	N/A
Completed	`NCT00576745` - A Comparison Of The 3M TM S Surgical Skin Closure System To The Standard Vicryl Suture Closure of Sternotomy Incisions During Cardiac Surgery	Phase 1
Completed	`NCT00402727` - Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection	Phase 3
Recruiting	`NCT00150852` - Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.	Phase 2
Not yet recruiting	`NCT03872544` - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting	`NCT04596124` - Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze	N/A
Active, not recruiting	`NCT04584957` - Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)	N/A
Recruiting	`NCT03960970` - Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries	Phase 2
Enrolling by invitation	`NCT03880188` - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Completed	`NCT02018094` - The Amputation Surgical Site Infection Trial (ASSIT)	Phase 4
Terminated	`NCT03269968` - Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery	N/A
Enrolling by invitation	`NCT02945761` - High Concentration of Sugar Solution Irrigation Promotes the Healing of Infected Wound	N/A
Not yet recruiting	`NCT02882360` - Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum	Phase 4